Wholesale and pharmacy margins on medicines in Europe

Every European country inserts two margins between the manufacturer and the patient: one for the wholesaler, one for the pharmacy. Those margins are set by regulation, they differ in structure as much as in size, and they are the reason two national prices for the same pack are not comparable until both have been normalised. This article sets out how the margins are built, which structures actually appear in Europe, and the three calculation traps that silently break a back calculation.

What a pharmaceutical trade margin actually is

A margin in this context is not a negotiated markup. It is a regulated maximum that defines the distance between two price levels, usually between the ex-factory price and the pharmacy purchase price, and between the pharmacy purchase price and the retail price. Four structures occur across Europe:

• Flat percentage. One rate applied to the whole price. Sweden uses 2.8 percent at distributor level, Finland 3 percent, Denmark 6.5 percent, Cyprus 9.25 percent.
• Degressive scale. The rate falls as the price rises, usually with a fixed component per band. Finland, Estonia, Croatia, Portugal, Slovenia and Cyprus all use scales.
• Fixed amount. A flat sum per pack rather than a percentage. Latvia adds a fixed distributor markup of 0.50 euro.
• Capped percentage. A percentage up to a ceiling, then a fixed amount. Germany caps the wholesale margin at 37.80 euro, and the cap applies from a manufacturer price of 1,200 euro upwards.

Combined margins also exist. Italy applies a combined pharmacy and distributor margin of 33.35 percent for the Classe A list, set in Decreto Legge 78/2010.

What the scales look like in practice

A degressive scale is a table of bands. Each band carries a factor and, in most countries, a fixed amount. The Finnish pharmacy scale is a good example because it has been checked numerically:

Legal basis: Valtioneuvoston asetus lääketaksasta. The same country adds a distributor margin of 3 percent, so a full back calculation from the Finnish consumer price runs through three steps: remove 13.5 percent VAT, remove the pharmacy scale, remove 3 percent.

Other structures in the same family:

• Estonia has eight pharmacy bands and five distributor bands, and both trade stages are capped at 6.39 euro per pack. A widespread description mentions only one of the two caps.
• Croatia uses eight distributor bands, and publishes ceilings rather than actual margins, so the back calculation yields an upper bound of the manufacturer price.
• Portugal uses six bands on a combined basis, calculated on the manufacturer price level.
• Slovenia uses two distributor bands with a factor of 1.011 plus 0.50 euro, and a fixed 27.50 euro above the upper band.
• Ireland applies a distributor markup of 8 percent, rising to 12 percent for cold chain products.

Trap one: the order of operations

Fixed amounts are removed first, then percentage rates. The rule sounds procedural and is decisive: a band with a fixed component produces a different result depending on the order, and the error is systematic rather than random. Every pack in that band is wrong by roughly the same amount, which makes the mistake hard to notice in aggregate statistics.

Trap two: the band basis

A margin scale can be read in two ways. Either the band is chosen by the purchase price, the price before the margin, or by the selling price, the price after it. The two readings put different packs into different bands near the boundaries.

This is decidable, not a matter of preference. Under the selling price reading, the Finnish scale is continuous at every band edge, with a largest jump of 0.0032 euro, which is rounding. Under the purchase price reading the same scale jumps by up to 12.73 euro. The continuity test therefore proves the reading, and the same test has confirmed the basis for Slovenia and Spain.

If you implement a national scale without running that test, you have a 50 percent chance of a systematic error on every pack near a band boundary.

Trap three: ceilings are not margins

Several countries publish maximum margins rather than applied margins. Croatia is the clearest case: the published figures are upper limits, so removing them returns the highest possible manufacturer price rather than the actual one. Labelling that result as a manufacturer price turns a legal maximum into an apparent fact.

The same logic applies to the price itself in most of Europe. A regulated price is a ceiling, and the transaction below it is not published anywhere.

Where margins sit on the manufacturer level, not the retail level

In Portugal and Spain the margin bands are defined on the manufacturer price level. Reading them as retail level bands produces a deviation of up to 3.23 euro per pack in Portugal. Spain's inversion follows Real Decreto-ley 4/2010, and the table has to be inverted rather than simply subtracted.

This is the single most common structural error in cross-country margin work, because most analysts assume that a margin table describes the step down from retail.

Margin structures across Europe at a glance

Read the last column before using any of these figures. Two of them are estimates carried over from an external margin assumption, one has no current legal basis, and one publishes ceilings rather than margins.

A worked example: three steps in Finland

Take a consumer price including tax from the Kela file and walk it down to the manufacturer level.

1. Remove VAT at 13.5 percent. In force since 1 January 2026, recalculated against 5,945 rows of the authority file.
2. Remove the pharmacy scale. Choose the band by the selling price, subtract the fixed component, then divide by the factor. For a pack in the second band that is 0.52 euro and a factor of 1.33.
3. Remove the distributor margin of 3 percent.

Three operations, three separate legal bases, and two of the three can be applied in the wrong order without producing an obviously wrong number. That is why the result should always carry a label stating which level it represents and which rule version produced it.

A short checklist before you normalise a price

1. Identify the published level, the target level and the steps between them.
2. Collect the statutory rule per step, with its legal basis and its effective date.
3. Apply fixed components before percentages.
4. Run the continuity test at every band edge to establish the band basis.
5. Check for caps, and check whether the cap applies to one stage or to both.
6. Mark ceiling based results as upper bounds, not as prices.
7. Record the date of the rule. Margins change: the French back calculation, for example, changes on 20 January 2027.

Conclusion

Trade margins are the mechanism that makes European drug prices incomparable at face value and comparable after careful normalisation. The structures are public, the legal bases are citable, and the three traps are all testable before a single figure is published. Anyone reporting a European price comparison without stating the level and the rules behind it is reporting the distribution system, not the price.

Related reading: European Drug Pricing Database: how cross-border prices work and Pharma pricing Germany: how the system works, plus ex-factory price and pharmacy purchase price.

pharmazie.com is the consolidated pharmaceutical data platform by DACON Datenbank Consulting GmbH that bundles 25+ specialist databases into a single search, exclusively for healthcare professionals. Price coverage focuses on the DACH region and a number of further EU countries, with more countries following in the coming months.